ERYTECH Pharma (ERYP) Short Interest Ratio & Short Volume

Short interest is the volume of ERYTECH Pharma shares that have been sold short but have not yet been covered or closed out. As of June 15th, traders have sold 17,800 shares of ERYP short. Learn More on ERYTECH Pharma's current short interest.

ERYTECH Pharma saw a drop in short interest during the month of June. As of June 15th, there was short interest totaling 17,800 shares, a drop of 53.0% from the previous total of 37,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to ERYTECH Pharma: Inhibikase Therapeutics, Inc. (4.93%), Protalix BioTherapeutics, Inc. (4.74%), ZIVO Bioscience, Inc. (1.77%), Calidi Biotherapeutics, Inc. (3.78%), Finch Therapeutics Group, Inc. (0.01%), AlloVir, Inc. (2.56%), NKGen Biotech, Inc. (1.16%), CEL-SCI Co. (7.40%), Chromocell Therapeutics Co. (8.70%), AIM ImmunoTech Inc. (414.92%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.80 billion), Canadian Natural Resources Limited ($3.69 billion), Charter Communications, Inc. ($2.95 billion), Occidental Petroleum Corporation ($2.78 billion), Moderna, Inc. ($2.38 billion), Palantir Technologies Inc. ($2.29 billion), T. Rowe Price Group, Inc. ($2.19 billion), Coinbase Global, Inc. ($2.08 billion), Royal Caribbean Cruises Ltd. ($2.02 billion), and Verisk Analytics, Inc. ($1.96 billion). View all of the most shorted stocks.

Short selling ERYP is an investing strategy that aims to generate trading profit from ERYTECH Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for ERYTECH Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ERYP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ERYP, twice per month. The most recent reporting period available is June, 15 2023.